Evidence map›Paper›PMID 23903009›Full record

ArticleTransplantation2013

Absence of FcγRIII results in increased proinflammatory response in FcγRIII-KO cardiac recipients.

Melek M Erdinc Sunay, Karen Fox-Talbot, Ergun Velidedeoglu, William M Baldwin, Barbara A Wasowska

Open access · greenAbstract read
In one paragraph

Article in Transplantation, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Acute and chronic rejection: compartmentalization and kinetics of counterbalancing signals in cardiac transplants.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2015
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Melek M Erdinc Sunay1 Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD. 2 Currently, Division of Special Pathogen and Transplant Products, Food and Drug Administration, Silver Spring, MD. 3 Currently, Department of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH. 4 Address correspondence to: Barbara A. Wasowska, Ph.D., 720 Rutland Avenue, Ross Building, #664B, Baltimore, MD 21205.
Karen Fox-Talbot
Ergun Velidedeoglu
William M Baldwin
Barbara A Wasowska
Johns Hopkins Medicine · USJohns Hopkins University · US

Funding

Surgery CoreP01AI087586 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI VALUJSKIKH, ANNA · 2010 to 2019
$17.2M
NIAID NIH HHS P01 AI087586NIAID NIH HHS P01AI087586
6 · The paper itself

Abstract

backgroundAlloantibody can contribute significantly to rejection of heart transplants by activation of complement and interactions with a variety of effector cells, including macrophages and monocytes through activating FcγRI, FcγRIII, FcγRIV, the inhibitory FcγRIIB and complement receptors. These receptors link cellular and humoral immunity by bridging the antibody specificity to effector cells. Activating FcγRs are also involved in serum amyloid P component (SAP)-mediated clearance of apoptotic bodies.

methodsB10.A (H-2a) hearts were transplanted into wild-type (WT) or FcγRIII-knockout (KO) C57BL/6 (H-2b) mouse recipients. Levels of alloantibodies and SAP in the circulation were determined by flow cytometry and enzyme-linked immunosorbent assay, respectively. Intragraft cytokine mRNA expression was measured by real-time polymerase chain reaction. Intragraft deposition of C4d, von Willebrand factor, SAP, and activated caspase 3 was visualized by immunochemistry.

resultsB10.A hearts in C57BL/6 FcγRIII-KO recipients were rejected acutely within 6 to 8 days compared with 10 to 14 days in WT. The rejection in FcγRIII-KO was accompanied by higher levels of circulating IgM/IgG alloantibodies and SAP than in WT recipients. Histology in FcγRIII-KO cardiac allograft recipients indicated perivascular margination of monocytes and neutrophils, vascular endothelial cell injury, and intense vasculocentric infiltrates with extensive apoptosis. Higher numbers of apoptotic cells, stronger C4d and SAP deposition, and extensive activated caspase 3 were found in areas of dense pockets of apoptotic blebs in FcγRIII-KO.

conclusionsWe propose that absence of FcγRIII is associated with the lack of efficient SAP-mediated clearance of apoptotic cells through FcγRs. Apoptotic cells become immunogenic and induce enhanced inflammation, alloantibody production, and complement activation leading to accelerated cardiac allograft rejection.

Indexed as

AnimalsApoptosisComplement ActivationCytokinesGraft RejectionGraft SurvivalHeart TransplantationInflammationInflammation MediatorsIsoantibodiesMaleMiceMice, Inbred C57BLMice, KnockoutMyocardiumReceptors, IgGCytokinesFcgr3 protein, mouseInflammation MediatorsIsoantibodiesReceptors, IgGSerum Amyloid P-Component

Identifiers

PMID23903009
PMCPMC3795861
OpenAlexW2043661501

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.